右哌甲酯所致的严重肌肉疼痛和僵硬。
Severe muscle pain and stiffness due to dexmethylphenidate.
作者信息
Kon Jacob J, Kon Alexander A
机构信息
Department of Pediatrics University of California San Diego School of Medicine San Diego CA USA.
出版信息
Clin Case Rep. 2020 Jan 25;8(3):420-422. doi: 10.1002/ccr3.2628. eCollection 2020 Mar.
Abstract
Dexmethylphenidate, and potentially other methylphenidates used in the treatment of attention deficit hyperactivity disorder (ADHD), may cause severe muscle pain and stiffness. Medication side effects should be considered as the possible cause if a patient with ADHD develops severe symptoms.
摘要
右旋哌甲酯以及其他可能用于治疗注意力缺陷多动障碍（ADHD）的哌甲酯类药物，可能会导致严重的肌肉疼痛和僵硬。如果患有ADHD的患者出现严重症状，应考虑药物副作用为可能的病因。
相似文献
1
Severe muscle pain and stiffness due to dexmethylphenidate.右哌甲酯所致的严重肌肉疼痛和僵硬。
Clin Case Rep. 2020 Jan 25;8(3):420-422. doi: 10.1002/ccr3.2628. eCollection 2020 Mar.
2
Dexmethylphenidate for attention deficit hyperactivity disorder.右苯丙胺治疗注意缺陷多动障碍。
Expert Opin Pharmacother. 2009 Nov;10(16):2679-85. doi: 10.1517/14656560903386284.
3
Dexmethylphenidate extended-release capsules for attention deficit hyperactivity disorder.用于治疗注意力缺陷多动障碍的右哌甲酯缓释胶囊
Expert Rev Neurother. 2005 Jul;5(4):437-41. doi: 10.1586/14737175.5.4.437.
4
A randomized, double-blind, crossover study of once-daily dexmethylphenidate in children with attention-deficit hyperactivity disorder: rapid onset of effect.一项针对注意力缺陷多动障碍儿童每日一次右苯丙胺的随机、双盲、交叉研究：起效迅速。
CNS Drugs. 2008;22(8):693-704. doi: 10.2165/00023210-200822080-00006.
5
Dexmethylphenidate extended release: a review of its use in the treatment of attention-deficit hyperactivity disorder.右苯丙胺控释片：用于治疗注意缺陷多动障碍的评价。
CNS Drugs. 2009 Dec;23(12):1057-83. doi: 10.2165/11201140-000000000-00000.
6
Update on methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder.注意缺陷多动障碍儿童用哌醋甲酯和右旋哌醋甲酯制剂的最新情况。
Am J Health Syst Pharm. 2021 May 6;78(10):840-849. doi: 10.1093/ajhp/zxab069.
7
Dexmethylphenidate extended release: in attention-deficit hyperactivity disorder.右旋哌甲酯缓释剂：用于注意缺陷多动障碍
Drugs. 2006;66(5):661-8; discussion 669-70. doi: 10.2165/00003495-200666050-00006.
8
Evaluating serdexmethylphenidate and dexmethylphenidate capsules as a once-daily treatment option for ADHD.评估塞地美芬酯和右美芬酯胶囊作为治疗注意力缺陷多动障碍（ADHD）的每日一次治疗选择。
Expert Opin Pharmacother. 2023 May-Aug;24(11):1215-1219. doi: 10.1080/14656566.2023.2218544. Epub 2023 May 26.
9
The safety and efficacy of methylphenidate and dexmethylphenidate in adults with attention deficit/hyperactivity disorder.哌甲酯和右哌甲酯用于成人注意力缺陷/多动障碍的安全性和有效性。
J Cent Nerv Syst Dis. 2010 Aug 3;2:15-30. doi: 10.4137/jcnsd.s4178. Print 2010.
10
Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study.Serdexmethylphenidate/Dexmethylphenidate 胶囊治疗注意缺陷多动障碍儿童的安全性和耐受性：一项为期 12 个月的开放标签安全性研究。
J Child Adolesc Psychopharmacol. 2023 Mar;33(2):51-58. doi: 10.1089/cap.2022.0076. Epub 2023 Feb 20.
本文引用的文献
1
Multisystem toxicity after methamphetamine use.使用甲基苯丙胺后的多系统毒性。
Clin Case Rep. 2016 Jan 11;4(3):226-7. doi: 10.1002/ccr3.487. eCollection 2016 Mar.
2
Amphetamine mechanisms and actions at the dopamine terminal revisited.重新审视安非他命在多巴胺终端的作用机制与行动。
J Neurosci. 2013 May 22;33(21):8923-5. doi: 10.1523/JNEUROSCI.1033-13.2013.
3
Toxicity of amphetamines: an update.苯丙胺类兴奋剂的毒性：最新研究进展。
Arch Toxicol. 2012 Aug;86(8):1167-231. doi: 10.1007/s00204-012-0815-5. Epub 2012 Mar 6.
4
The genetic toxicity of methylphenidate: a review of the current literature.哌醋甲酯的遗传毒性：当前文献综述。
J Appl Toxicol. 2012 Oct;32(10):756-64. doi: 10.1002/jat.2721. Epub 2012 Feb 15.
5
Dopamine triggers skeletal muscle tone by activating D1-like receptors on somatic motoneurons.多巴胺通过激活躯体运动神经元上的 D1 样受体触发骨骼肌张力。
J Neurophysiol. 2011 Sep;106(3):1299-309. doi: 10.1152/jn.00230.2011. Epub 2011 Jun 8.
6
Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A).美国青少年精神障碍终身患病率：全国共病调查再现-青少年增补研究（NCS-A）的结果。
J Am Acad Child Adolesc Psychiatry. 2010 Oct;49(10):980-9. doi: 10.1016/j.jaac.2010.05.017. Epub 2010 Jul 31.
7
Prevalence and treatment of mental disorders among US children in the 2001-2004 NHANES.2001-2004 年美国国家健康与营养调查中儿童精神障碍的流行状况和治疗情况。
Pediatrics. 2010 Jan;125(1):75-81. doi: 10.1542/peds.2008-2598. Epub 2009 Dec 14.
8
The Motor Function Neurological Assessment (MFNU) as an indicator of motor function problems in boys with ADHD.多动障碍男孩运动功能的运动功能神经学评估（MFNU）指标。
Behav Brain Funct. 2009 May 18;5:22. doi: 10.1186/1744-9081-5-22.
9
Methylphenidate improves motor functions in children diagnosed with Hyperkinetic Disorder.哌醋甲酯可改善多动障碍患儿的运动功能。
Behav Brain Funct. 2009 May 13;5:21. doi: 10.1186/1744-9081-5-21.
10
Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer.哌甲酯的短期疗效：一项针对儿童癌症幸存者的随机、双盲、安慰剂对照试验。
J Clin Oncol. 2004 Dec 1;22(23):4795-803. doi: 10.1200/JCO.2004.04.128.
Zotero 插件